Alembic Pharmaceuticals Ltd

Announcement under Regulation 30 (LODR)-Press Release / Media Release

01:28 PM, 15th May 2025

Alembic Pharmaceuticals receives USFDA Final Approval for Rivaroxaban Tablets USP 2.5 mg 10 mg 15 mg and 20 mg